Quantitative assessment of metabolic tumor burden in molecular subtypes of primary breast cancer with FDG PET/CT.

CONCLUSION: Metabolic tumor burden could comprehensively reflect tumor metabolic differences of molecular subtypes of breast cancer, and it can serve to help differentiate patients with basal-like breast cancer. PMID: 30406761 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30406761?dopt=Abstract

Source: Diagnostic and Interventional Radiology : The Turkish Society of Radiology - November 1, 2018 Category: Radiology Authors: Chen W, Zhu L, Yu X, Fu Q, Xu W, Wang P Tags: Diagn Interv Radiol Source Type: research